03:35 PM EST - Vivione Biosciences Inc. : announced the successful completion of its early stage pilot study at the Cleveland Clinic focused on applying its RAPID-B bacterial detection platform to the primary screening of suspected urinary tract infections. Vivione Biosciences Inc.
shares V.VBI are trading unchanged at $0.20.
